309 results on '"Probert, C S"'
Search Results
2. Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis
3. Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease
4. Review article: cytomegalovirus and inflammatory bowel disease
5. Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease
6. Prevalence of an Ulcerative Colitis-Associated CD8+ T Cell Receptor β-Chain CDR3-Region Motif and Its Association with Disease Activity1
7. South Asians with ulcerative colitis exhibit altered lectin binding compared with matched European cases
8. Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues
9. T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking
10. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohnʼs disease
11. Review article: steroid resistance in inflammatory bowel disease – mechanisms and therapeutic strategies
12. maintenance therapy in patients with ulcerative colitis
13. Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease
14. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
15. Mortality in patients with ulcerative colitis in Leicestershire, 1972–1989: An epidemiological study
16. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study
17. Is mesalazine really safe for use in breastfeeding mothers?
18. Rapid hip bone loss in active Crohnʼs disease patients receiving short-term corticosteroid therapy
19. A novel method for rapidly diagnosing the causes of diarrhoea
20. Parenteral nutrition via an arteriovenous bypass graft
21. Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis
22. Refeeding syndrome: effective and safe treatment with Phosphates Polyfusor
23. Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds
24. A man with a murmur requiring nutritional support
25. A difficult case of gastrointestinal haemorrhage
26. An 80 year old woman with intermittent severe vomiting
27. Measles, month of birth, and Crohnʼs disease
28. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes
29. Oral iron exacerbates colitis and influences the intestinal microbiome
30. P842 Multi-omics analysis suggests an active role of fungi in Crohn’s disease
31. Is Factor V Leiden associated with inflammatory bowel disease? 22.05
32. Stoma anxieties: A comparison of the attitudes of Asian migrants and the indigenous population in the United Kingdom towards abdominal surgery and the role of intestinal stomas
33. Diet, Diabetes, And Male Chauvinism
34. Achalasia and diet: Assessment of the effect of achalasia on the diet of patients and their spouses
35. Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis
36. Biologics in ulcerative colitis
37. Towards point of care testing forC. difficileinfection by volatile profiling, using the combination of a short multi-capillary gas chromatography column with metal oxide sensor detection
38. The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients
39. Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.
40. PTU-076 Diagnostic Potential of Volatile Organic Compounds as Faecal Biomarkers in Inflammatory Bowel Disease
41. PTU-077 Diagnostic Potential of Volatile Organic Compounds as Urine Biomarkers in Inflammatory Bowel Disease
42. Volatiles from oral anaerobes confounding breath biomarker discovery
43. PWE-225 Efficacy of faecal lactoferrin in IBS and IBD: a comparative study
44. PWE-004 A study of faecal volatile organic compounds metabolome in healthy population across the countries
45. PWE-287 Breath volatile analysis for the recognition of harmful drinking, cirrhosis and hepatic encephalopathy
46. Assessment of adherence to mesalazine maintenance therapy over 1 year using memscaps monitoring system: a substudy of the coda trial comparing once- versus three times daily asacol in ulcerative colitis (UC)
47. Once daily Asacol
48. Endoscopy can be avoided in the assessment of ulcerative colitis in clinical trials
49. OC-005 Does irritable bowel syndrome smell different from irritable bowel disease? A study of faecal volatile analysis in inflammatory bowel syndrome
50. Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.